Approvals/TGA/SIMPONI golimumab (rmc) 100 mg solution for injection pre-filled syringe

Approved

STANDARD

SIMPONI golimumab (rmc) 100 mg solution for injection pre-filled syringe

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c0d33f36b6857fe5
Product Name: SIMPONI golimumab (rmc) 100 mg solution for injection pre-filled syringe
Artg Id: 208278
Artg Name: SIMPONI golimumab (rmc) 100 mg solution for injection pre-filled syringe
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2014-04-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-03026-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-03025-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

c0d33f36b6857fe5

Type

Standard